TrialBMC cancer2026

Reduced-dose nanoparticle albumin-bound-paclitaxel combined with ramucirumab as second-line treatment for advanced gastric cancer: a multicenter phase II study.

Michihisa Iida et al.PubMed ↗Publisher ↗

No numbers read from the abstract.